Relationship of Bone Turnover Markers with Serum Uric Acid-to-Creatinine Ratio in Men and Postmenopausal Women with Type 2 Diabetes

References

• Saeedi P, Petersohn I, Salpea P., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Kim B, Lee SH, Song SJ, et al. Protective effects of melon extracts on bone strength, mineralization, and metabolism in rats with ovariectomy-induced osteoporosis. Antioxidants. 2019;8(8):306. doi:10.3390/antiox8080306
   Web of Science ®Google Scholar
• Das S, Crockett JC. Osteoporosis - a current view of pharmacological prevention and treatment. Drug Des Devel Ther. 2013;7:435–448. doi:10.2147/DDDT.S31504
   PubMed Web of Science ®Google Scholar
• Qu B, Ma Y, Yan M, et al. The economic burden of fracture patients with osteoporosis in western China. Osteoporos Int. 2014;25(7):1853–1860. doi:10.1007/s00198-014-2699-0
   Web of Science ®Google Scholar
• Si Y, Wang C, Guo Y, Xu G, Ma Y. Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese Mainland: a systematic review and meta-analysis. Iran J Public Health. 2019;48(7):1203–1214.
   PubMed Web of Science ®Google Scholar
• Oei L, Rivadeneira F, Zillikens MC, Oei EH. Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep. 2015;13(2):106–115. doi:10.1007/s11914-015-0260-5
   PubMed Web of Science ®Google Scholar
• Hu F, Jiang C, Shen J, Tang P, Wang Y. Preoperative predictors for mortality following Hip fracture surgery: a systematic review and meta-analysis. Injury. 2012;43(6):676–685. doi:10.1016/j.injury.2011.05.017
   PubMed Web of Science ®Google Scholar
• Dong XW, Tian HY, He J, Wang C, Qiu R, Chen YM. Elevated serum uric acid is associated with greater bone mineral density and skeletal muscle mass in middle-aged and older adults. PLoS One. 2016;11(5):e0154692. doi:10.1371/journal.pone.0154692
   Web of Science ®Google Scholar
• Yan DD, Wang J, Hou XH, et al. Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population. Acta Pharmacol Sin. 2018;39(4):626–632. doi:10.1038/aps.2017.165
   PubMed Web of Science ®Google Scholar
• Zhao DD, Jiao PL, Yu JJ, et al. Higher serum uric acid is associated with higher bone mineral density in Chinese men with type 2 diabetes mellitus. Int J Endocrinol. 2016;2016:2528956. doi:10.1155/2016/2528956
   Web of Science ®Google Scholar
• Tanaka KI, Kanazawa I, Notsu M, Sugimoto T. Higher serum uric acid is a risk factor of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2020;128(1):66–71. doi:10.1055/a-0815-4954
   Web of Science ®Google Scholar
• Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 2007;18(4):427–444. doi:10.1007/s00198-006-0253-4
   PubMed Web of Science ®Google Scholar
• Cabral HW, Andolphi BF, Ferreira BV, et al. The use of biomarkers in clinical osteoporosis. Rev Assoc Med Bras. 2016;62(4):368–376. doi:10.1590/1806-9282.62.04.368
   PubMed Web of Science ®Google Scholar
• Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R. T-cell mediated inflammation in postmenopausal osteoporosis. Front Immunol. 2021;12:687551. doi:10.3389/fimmu.2021.687551
   PubMed Web of Science ®Google Scholar
• Taslamacioglu Duman T, Zahid Kocak M, Meryem Atak B, et al. Serum Uric acid is correlated with HbA1c levels in type 2 diabetes mellitus. Exp Biomed Res. 2018;1(1):6–9. doi:10.30714/j-ebr.2018136918
   Google Scholar
• Kocak MZ, Aktas G, Duman TT, Atak BM, Savli H. Is uric acid elevation a random finding or a causative agent of diabetic nephropathy? Rev Assoc Med Bras. 2019;65(9):1155–1160. doi:10.1590/1806-9282.65.9.1156
   PubMed Web of Science ®Google Scholar
• Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297–302. doi:10.1080/00325481.2022.2039007
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 2021;67(4):549–554. doi:10.1590/1806-9282.20201005
   PubMed Web of Science ®Google Scholar
• Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021;59(4):403–408. doi:10.2478/rjim-2021-0023
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 2019;65(1):9–15. doi:10.1590/1806-9282.65.1.9
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–1102. doi:10.1080/13685538.2019.1678126
   PubMed Web of Science ®Google Scholar
• Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5(11):908–923. doi:10.1016/S2213-8587(17)30184-5
   PubMed Web of Science ®Google Scholar
• Fontalis A, Eastell R. The challenge of long-term adherence: the role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosis. Bone. 2020;136:115336. doi:10.1016/j.bone.2020.115336
   Web of Science ®Google Scholar
• Bauer D, Krege J, Lane N, et al. National bone health alliance bone turnover marker project: current practices and the need for US harmonization, standardization, and common reference ranges. Osteoporos Int. 2012;23(10):2425–2433. doi:10.1007/s00198-012-2049-z
   PubMed Web of Science ®Google Scholar
• Cosman F, de Beur SJ, LeBoff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381. doi:10.1007/s00198-014-2794-2
   PubMed Web of Science ®Google Scholar
• Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem. 2017;63(2):464–474. doi:10.1373/clinchem.2016.259085
   PubMed Web of Science ®Google Scholar
• Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab. 2006;52(9–10):499–509.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Apekey TA, Laukkanen JA. Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence. Eur J Epidemiol. 2015;30(8):599–614. doi:10.1007/s10654-015-0058-x
   PubMed Web of Science ®Google Scholar
• Picke AK, Campbell G, Napoli N, Hofbauer LC, Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect. 2019;8(3):R55–r70. doi:10.1530/EC-18-0456
   PubMed Web of Science ®Google Scholar
• Kasperk C, Georgescu C, Nawroth P. Diabetes mellitus and bone metabolism. Exp Clin Endocrinol Diabetes. 2017;125(4):213–217. doi:10.1055/s-0042-123036
   Web of Science ®Google Scholar
• Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL. Mechanisms in endocrinology: diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol. 2017;176(3):R137–r157. doi:10.1530/EJE-16-0652
   PubMed Web of Science ®Google Scholar
• Compston J. Type 2 diabetes mellitus and bone. J Intern Med. 2018;283(2):140–153. doi:10.1111/joim.12725
   PubMed Web of Science ®Google Scholar
• Oei L, Zillikens MC, Dehghan A, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care. 2013;36(6):1619–1628. doi:10.2337/dc12-1188
   PubMed Web of Science ®Google Scholar
• Watts NB, Bilezikian JP, Usiskin K, et al. Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2016;101(1):157–166. doi:10.1210/jc.2015-3167
   PubMed Web of Science ®Google Scholar
• Nabipour I, Sambrook PN, Blyth FM, et al. Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res. 2011;26(5):955–964. doi:10.1002/jbmr.286
   Web of Science ®Google Scholar
• Ahn SH, Lee SH, Kim BJ, et al. Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporos Int. 2013;24(12):2961–2970. doi:10.1007/s00198-013-2377-7
   PubMed Web of Science ®Google Scholar
• Xu M, Su J, Hao J, et al. Positive association between serum uric acid and bone mineral density in Chinese type 2 diabetes mellitus stratified by gender and BMI. J Bone Miner Metab. 2018;36(5):609–619. doi:10.1007/s00774-017-0877-9
   Web of Science ®Google Scholar
• Hwang IC, Suh SY, Suh AR, Ahn HY. The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J Korean Med Sci. 2011;26(3):386–391. doi:10.3346/jkms.2011.26.3.386
   PubMed Web of Science ®Google Scholar
• Zhu Y, Hu Y, Huang T, et al. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014;447(4):707–714. doi:10.1016/j.bbrc.2014.04.080
   PubMed Web of Science ®Google Scholar
• Huang S, Kaw M, Harris MT, et al. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone. 2010;46(4):1138–1145. doi:10.1016/j.bone.2009.12.020
   PubMed Web of Science ®Google Scholar
• Guo H, Wang C, Jiang B, et al. Association of insulin resistance and β-cell function with bone turnover biomarkers in dysglycemia patients. Front Endocrinol. 2021;12:554604. doi:10.3389/fendo.2021.554604
   PubMed Web of Science ®Google Scholar
• Liu JM, Rosen CJ, Ducy P, Kousteni S, Karsenty G. Regulation of glucose handling by the skeleton: insights from mouse and human studies. Diabetes. 2016;65(11):3225–3232. doi:10.2337/db16-0053
   Web of Science ®Google Scholar
• Salsali A, Nathan M. A review of types 1 and 2 diabetes mellitus and their treatment with insulin. Am J Ther. 2006;13(4):349–361. doi:10.1097/00045391-200607000-00012
   PubMedGoogle Scholar
• Zhang W, Shen X, Wan C, et al. Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK. Cell Biochem Funct. 2012;30(4):297–302. doi:10.1002/cbf.2801
   Web of Science ®Google Scholar
• Strollo R, Rizzo P, Spoletini M, et al. HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus. Diabetologia. 2013;56(3):563–572. doi:10.1007/s00125-012-2780-1
   Web of Science ®Google Scholar
• Wongdee K, Charoenphandhu N. Update on type 2 diabetes-related osteoporosis. World J Diabetes. 2015;6(5):673–678. doi:10.4239/wjd.v6.i5.673
   PubMedGoogle Scholar
• Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:455–468. doi:10.2147/TCRM.S131945
   PubMed Web of Science ®Google Scholar
• Epstein S, Defeudis G, Manfrini S, Napoli N, Pozzilli P. Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition. Osteoporos Int. 2016;27(6):1931–1951. doi:10.1007/s00198-015-3454-x
   PubMed Web of Science ®Google Scholar
• Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JE. Diabetes and advanced glycoxidation end products. Diabetes Care. 2006;29(6):1420–1432. doi:10.2337/dc05-2096
   PubMed Web of Science ®Google Scholar
• Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study. Eur J Clin Nutr. 2003;57(10):1262–1267. doi:10.1038/sj.ejcn.1601683
   Web of Science ®Google Scholar
• Zhou Y, Li Y, Zhang D, Wang J, Yang H. Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Res Clin Pract. 2010;90(3):261–269. doi:10.1016/j.diabres.2010.09.013
   Web of Science ®Google Scholar
• de Liefde II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int. 2005;16(12):1713–1720. doi:10.1007/s00198-005-1909-1
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–865. doi:10.1016/S0140-6736(98)07037-8
   PubMed Web of Science ®Google Scholar
• Majumdar SR, Leslie WD, Lix LM, et al. Longer duration of diabetes strongly impacts fracture risk assessment: the Manitoba BMD cohort. J Clin Endocrinol Metab. 2016;101(11):4489–4496. doi:10.1210/jc.2016-2569
   PubMed Web of Science ®Google Scholar
• Du YJ, Liu NN, Zhong X, Pan TR. Risk factors for nonalcoholic fatty liver disease in postmenopausal women with type 2 diabetes mellitus and the correlation with bone mineral density at different locations. Diabetes Metab Syndr Obes. 2022;15:1925–1934. doi:10.2147/DMSO.S364804
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57–63. doi:10.2337/diacare.23.1.57
   PubMed Web of Science ®Google Scholar
• Vasques AC, Novaes FS, de Oliveira Mda S, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. doi:10.1016/j.diabres.2011.05.030
   PubMed Web of Science ®Google Scholar
• Bloomgarden ZT. Diabetic nephropathy. Diabetes Care. 2005;28(3):745–751. doi:10.2337/diacare.28.3.745
   PubMedGoogle Scholar
• Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164–176. doi:10.2337/diacare.28.1.164
   PubMed Web of Science ®Google Scholar
• Luo P, Cao Y, Li P, et al. TyG index performs better than HOMA-IR in Chinese type 2 diabetes mellitus with a BMI < 35 kg/m(2): a hyperglycemic clamp validated study. Medicina. 2022;58(7). doi:10.3390/medicina58070876
   Web of Science ®Google Scholar
• Almeida M, Han L, Martin-Millan M, O’Brien CA, Manolagas SC. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem. 2007;282(37):27298–27305. doi:10.1074/jbc.M702811200
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Smith T, Nicolson B, et al. Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum. 2008;58(6):1854–1865. doi:10.1002/art.23488
   Web of Science ®Google Scholar
• Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208–219. doi:10.1038/nrendo.2016.153
   PubMed Web of Science ®Google Scholar
• Yamada T, Suzuki S, Fukatsu M, Wada T, Yoshida T, Joh T. Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. Acta Gastroenterol Belg. 2010;73(1):12–17.
   PubMed Web of Science ®Google Scholar
• Lanaspa MA, Sanchez-Lozada LG, Cicerchi C, et al. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS One. 2012;7(10):e47948. doi:10.1371/journal.pone.0047948
   PubMed Web of Science ®Google Scholar
• Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 2007;293(2):C584–596. doi:10.1152/ajpcell.00600.2006
   PubMed Web of Science ®Google Scholar
• Ghaemi-Oskouie F, Shi Y. The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep. 2011;13(2):160–166. doi:10.1007/s11926-011-0162-1
   PubMed Web of Science ®Google Scholar
• Hill JR, Kwon G, Marshall CA, McDaniel ML. Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C. J Biol Chem. 1998;273(6):3308–3313. doi:10.1074/jbc.273.6.3308
   Web of Science ®Google Scholar
• Spindler MP, Ho AM, Tridgell D, et al. Acute hyperglycemia impairs IL-6 expression in humans. Immun Inflamm Dis. 2016;4(1):91–97. doi:10.1002/iid3.97
   Google Scholar
• Gonzalez Y, Herrera MT, Soldevila G, et al. High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes. BMC Immunol. 2012;13:19. doi:10.1186/1471-2172-13-19
   PubMed Web of Science ®Google Scholar
• Nesto R. C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med. 2004;21(8):810–817. doi:10.1111/j.1464-5491.2004.01296.x
   Web of Science ®Google Scholar
• Boyce BF, Yao Z, Xing L. Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci. 2010;1192:367–375. doi:10.1111/j.1749-6632.2009.05315.x
   PubMed Web of Science ®Google Scholar
• Wu ZQ, Zhang Y, Xie E, et al. High uric acid (UA) negatively affects serum tartrate-resistant acid phosphatase 5b (TRACP 5b) Immunoassay. PLoS One. 2016;11(1):e0147554. doi:10.1371/journal.pone.0147554
   Web of Science ®Google Scholar
• Li HZ, Chen Z, Hou CL, Tang YX, Wang F, Fu QG. Uric acid promotes osteogenic differentiation and inhibits adipogenic differentiation of human bone mesenchymal stem cells. J Biochem Mol Toxicol. 2015;29(8):382–387. doi:10.1002/jbt.21707
   Web of Science ®Google Scholar